Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations-Reference-Cited by-同舟云学术

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations

Published:2018-08-17 Issue:8 Volume:13 Page:e0200836
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pal Rekha,Wei Ning,Song Nan,Wu Shaoyu,Kim Rim S.,Wang Ying,Gavin Patrick G.,Lucas Peter C.,Srinivasan Ashok,Allegra Carmen J.,Jacobs Samuel A.,Paik Soonmyung^ORCID,Schmitz John C.,Pogue-Geile Katherine L.^ORCID

Funder

Pennsylvania Department of Health

Cancer Institute, University of Pittsburgh

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. A colorectal cancer classification system that associates cellular phenotype and responses to therapy;A Sadanandam;Nat Med,2013

2. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions;F De Sousa E Melo;Nat Med,2013

3. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition;P Roepman;Int J Cancer,2014

4. Clinical outcome from oxaliplatin treatment in stage II/III colon cancer according to intrinsic subtypes: Secondary analysis of NSABP C-07/NRG Oncology randomized clinical trial;N Song;JAMA Oncol,2016

5. Epidermal growth factor receptor pathway mutations and colorectal cancer therapy;AH Grossmann;Arch Pathol Lab Med,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy;Cancer Research Communications;2024-08-01

2. NetCellMatch: Multiscale Network‐Based Matching of Cancer Cell Lines to Patients Using Graphical Wavelets;Chemistry & Biodiversity;2022-11-28

3. The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy;Frontiers in Pharmacology;2022-05-13

4. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis;JNCI: Journal of the National Cancer Institute;2021-06-02

5. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo;Cancers;2021-02-28